| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |